PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

PROCEPT BioRobotics faces a securities fraud class action lawsuit for failing to disclose material inventory issues. The company revealed that handpiece sales had materially exceeded procedures since Q1 2023, resulting in over 10,000 units of excess field inventory. This disclosure caused the stock to decline 18% in two days, from $27.84 to $22.69 per share, as quarterly handpiece sales dropped nearly 30% and the company missed annual revenue guidance by tens of millions of dollars. Investors have until September 22, 2026 to file lead plaintiff applications.